Oxurion (Euronext Brussels: OXUR - formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.

Biotechnology

Oxurion

Oxurion's headquarters in Leuven, Belgium

Pascal Ghoson

Eva Padgett

Alfred Aronson

Philippe B.

An Huysmans

Kathleen Paisley

Grace Chang

Linda Knott

David Guyer

Baron Philippe Vlerick

Adrienne Graves

The Corporate Governance team at Oxurion is responsible for ensuring that the company adheres to legal and regulatory standards while promoting accountability and ethical practices. Comprising non-executive directors and legal counsel, the team oversees board activities, manages compliance with corporate governance principles, and supports strategic decision-making to foster transparency and safeguard shareholder interests.

Corporate Governance

The Medical and Scientific Team at Oxurion is dedicated to advancing the company's portfolio of vision-preserving therapies through rigorous research and clinical development. They collaborate on scientific investigations, support strategic medical communications, and ensure the safe and effective application of treatments for ocular diseases. This team plays a critical role in optimizing drug development processes, engaging with healthcare professionals, and translating complex scientific concepts into actionable insights.

Medical and Scientific Team

This department provides strategic direction and oversight for the organization, focusing on high-level decision-making and governance.

Executive Leadership

This department focuses on global information and communications technology strategies and consulting.

Information and Communications

The Leadership Team at Oxurion is responsible for strategic decision-making and oversight of the company's biopharmaceutical operations. Comprising key executives such as the Chief Development Officer and Chief Medical Officer, the team focuses on advancing innovative treatments, ensuring regulatory compliance, and driving corporate governance to enhance patient outcomes in vision-related diseases. They work collaboratively to steer the company's vision, aligning scientific, legal, and operational strategies with market needs.

Leadership Team

This department manages employee relations, recruitment, and organizational development.

Oxurion

Org chart

Board & advisors

Teams

Corporate Governance

Medical and Scientific Team

Executive Leadership

Information and Communications

Leadership Team

Human Resources

Offices

Oxurion

Org chart

Board & advisors

Teams

Corporate Governance

Medical and Scientific Team

Executive Leadership

Information and Communications

Leadership Team

Human Resources

Offices

Related companies